Send feedback

CAPN3 p.Glu323Ter

c.967G>T · rs750443041 · VCV620114

Pathogenic Expert panel
Classification
Pathogenic
ClinVar
Review
Expert panel ★★★☆
ClinVar · 8 submitters
Consequence
nonsense (stop-gain)
predicted LoF
gnomAD v4.1
Rare
very rare (popmax 8.48e-05%, nfe)
Conditions
3
autosomal recessive limb-girdle muscular dystrophy

ClinGen expert panel — Limb Girdle Muscular Dystrophy VCEP

Pathogenic for autosomal recessive limb-girdle muscular dystrophy. Applied ACMG criteria (verbatim):

PVS1 PM2_Supporting PP4 PM3

Curation rationale (ClinGen, verbatim)

The NM_000070.3: c.967G>T p.(Glu323Ter) variant in CAPN3, which is also known as p.(Glu323del), is a nonsense variant predicted to cause a premature stop codon in biologically relevant exon 7/24, leading to nonsense mediated decay in a gene in which loss of function is an established disease mechanism (PVS1). This variant has been detected in trans with a likely pathogenic or pathogenic variant in an individual with limb girdle muscular dystrophy (c.146G>A p.(Arg49His), 1.0 pt, PMID: 17318636) (PM3). At least one patient with this variant displayed progressive limb girdle muscle weakness or a clinical suspicion of LGMD (PMID: 17318636; PP4). The highest population minor allele frequency in gnomAD v2.1.1 is 0.000008802 (1/113610 exome alleles) in the European (non-Finnish) population, which is lower than the LGMD VCEP threshold (<0.0001) for PM2_Supporting, meeting this criterion (PM2_Supporting). In summary, this variant meets the criteria to be classified as Pathogenic for autosomal recessive limb girdle muscular dystrophy based on the ACMG/AMP criteria applied, as specified by the ClinGen LGMD VCEP (LGMD VCEP specifications version 1.0.0; 01/09/2025): PVS1, PM3, PP4, PM2_Supporting.

ClinGen Evidence Repository → · reported verbatim, not re-tallied by Sugi Variant.

Computational evidence

Protein change
Missense predictors do not apply to this variant type; conservation/SpliceAI carries the signal.
Consequencenonsense (stop-gain)predicted loss-of-function
NMDpredictedpremature termination codon in exon 7 of 24
Splicing
SpliceAIΔ0.43acceptor loss, 21 bp away · masked 0 · deltas
PangolinΔ0.32loss · gain 0.01 · agrees with SpliceAI · independent
Constraint at this position
ConservationphyloP 12GERP 2.7, phastCons 1
Overall
CADD45.0PHRED · no single calibrated threshold — expert panels disagree

Predicted loss-of-function is descriptive, not an applied PVS1 code.

Population frequency

gnomAD v4.1 · exomes + genomes
Grpmax group 8.48e-05% European (non-Finnish) · 1/1,179,880 alleles
Overall 6.84e-05% 1/1,461,646 alleles · very rare

Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.

Variant & gene context

Gene
CAPN3
Protein
p.Glu323Ter
Coding
c.967G>T
MANE Select
NM_000070
dbSNP
rs750443041
Type
single nucleotide variant
Location
chr15:42392660 (GRCh38)
Gene constraint
LOEUF 0.896 · pLI <0.01 · ClinGen HI gene assoc. with recessive phenotype (gnomAD)
Structure
AlphaFold pLDDT 79.18 · 5 PDB
Residue 323
the calpain catalytic domain
Full CAPN3 gene report on Sugi Atlas → Gene function, pathways, protein structure, interactions & more

Similar variants

Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →

Cite Sugi Variant

Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/capn3-p-glu323ter (accessed [today's date]).

Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown